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I M M U N O L O G Y
The chaperonin CCT controls T cell receptor–driven  
3D configuration of centrioles
N. B. Martin-Cofreces1,2,3*†, F. J. Chichon4†, E. Calvo3,5, D. Torralba1,2, E. Bustos-Moran1,2, 
S. G. Dosil1,2, A. Rojas-Gomez1,2, E. Bonzon-Kulichenko3,5, J. A. Lopez5, J. Otón6, A. Sorrentino7, 
J. C. Zabala8, I. Vernos9,10,11, J. Vazquez3,5, J. M. Valpuesta4*‡, F. Sanchez-Madrid1,2,3*‡
T lymphocyte activation requires the formation of immune synapses (IS) with antigen-presenting cells. The dynamics 
of membrane receptors, signaling scaffolds, microfilaments, and microtubules at the IS determine the potency of 
T cell activation and subsequent immune response. Here, we show that the cytosolic chaperonin CCT (chaperonin- 
containing TCP1) controls the changes in reciprocal orientation of the centrioles and polarization of the tubulin 
dynamics induced by T cell receptor in T lymphocytes forming an IS. CCT also controls the mitochondrial ultra-
structure and the metabolic status of T cells, regulating the de novo synthesis of tubulin as well as posttranslational 
modifications (poly-glutamylation, acetylation, 1 and 2) of -tubulin heterodimers, fine-tuning tubulin dynamics. 
These changes ultimately determine the function and organization of the centrioles, as shown by three-dimensional 
reconstruction of resting and stimulated primary T cells using cryo-soft x-ray tomography. Through this mechanism, 
CCT governs T cell activation and polarity.
INTRODUCTION
The centrosome is a nonmembranous organelle in charge of orga-
nizing the microtubule (MT) network, maintaining the global orga-
nization of cellular organelles and intracellular transport between 
different organelles during interphase in eukaryotic cells from animal 
origin. It is formed by two barrel-shaped structures called centri-
oles, surrounded by an amorphous material, called the pericentriolar 
matrix (PCM) (1). The centrosome has been shown to play an ac-
tive role during immune synapse (IS) formation, helping sustained 
activation in CD4 T cells (2) and guiding the polarized translocation 
of the intracellular secretory machinery and organelles toward the 
contact area with the antigen-presenting cell (APC) in CD4 and CD8 
T cells for specific cell-cell communication (3–5). Centrosome po-
sitioning at the IS is considered a hallmark for T cell activation (6).
Local redistribution of specific plasma membrane receptors and 
cytosolic protein clusters is observed during IS formation (7), which 
is associated with cytoskeletal reorganization (8, 9). Mitochondria 
are the organelles that control cellular metabolism, and during T cell 
activation, they undergo changes in their shape and localization, 
which determine their ability to produce adenosine 5′-triphosphate 
(ATP). This is reflected by changes in the mitochondrial membrane 
potential, influencing the proton gradient across the membrane. 
The movement of mitochondria toward the IS has been previously 
reported; drp-1 (dynamin-related protein 1) is needed to reduce 
their size for proper accumulation at the IS along MTs to aid T cell 
activation (10). Localization of mitochondria at the IS provides con-
trol of local calcium (11) and ATP levels (10).
Despite its prominent role in T cell activation, the molecular 
mechanisms controlling centrosome-related proteostasis (including 
protein synthesis, transport into and out of the centrosome area, 
and degradation) and internal organization at the IS are mostly un-
known. Through Systems Biology analysis, we identified the increase 
in cytosolic CCT chaperonin in centrosome fractions from IS-forming 
T lymphocytes. Proteins must undergo complex folding processes 
to be fully functional, and a number of proteins require the help of 
molecular chaperones to acquire their correct three-dimensional 
(3D) structure. The eukaryotic cytosolic chaperonin-containing TCP1 
[CCT; also called TRiC (TCP1 ring complex)] is a large macro-
molecular complex (~1 MDa) made up of two copies of eight ho-
mologous subunits that assemble to form a double-ring structure 
(12–14). The 3D ultrastructure of activated, polarized T cells by cryo- 
soft x-ray tomography (cryo-SXT), stimulated emission depletion 
(STED) confocal microscopy, and live cell total internal reflection 
fluorescence microscopy (TIRFm) showed that interfering with CCT 
expression prevents correct centriolar and mitochondrial ultra-
structure and localization. Our findings link the de novo synthesis 
of tubulin and MT dynamics through CCT function, which ultimately 
regulate cell polarity.
RESULTS
T cell receptor–driven changes in pericentriolar  
proteome composition
To address possible coordinated changes in protein complexes at the 
centrosome area during T cell activation, we first compared using 
quantitative mass spectrometry–based proteomics: isobaric tags for 
relative and absolute quantitation (iTRAQ), centrosome- enriched 
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fractions from CD3/CD28-activated and resting human primary T 
lymphocytes (as depicted in Fig. 1A and fig. S1A), to discover clusters 
of proteins whose amount change upon activation at the centrosomal 
region. We used an approach based on cold to stop activation and 
initiated centrosome isolation (15) avoiding cytoskeleton- disrupting 
drugs such as nocodazole or cytochalasin D, which are known to impair 
T cell activation (8). The steps for biochemical isolation are depicted 
in fig. S1A (15, 16). We confirmed that activated centrosomes were able 
to increase in vitro polymerization of tubulin when used as lattices 
(Fig. 1B), suggesting a centrosome maturation process upon T cell recep-
tor (TCR) activation. CCT was highly enriched in the centrosome area 
upon T cell activation. CCT participates in the folding of a number of 
substrates such as tubulin and actin and constitutes a nonpromiscuous 
chaperonin compared to other known chaperones (17). CCT allows 
-tubulin heterodimers to form for further incorporation into MTs, 
helped by tubulin cofactors (TBCs) (18). Quantitative data from six bio-
logical replicates were subjected to statistical and systems analysis using 
the Systems Biology Triangle (SBT) model to detect coordinated protein 
responses (Fig. 1, C and D; fig. S1B; and tables S1 and S2) (19).
The coordinated increases in some protein groups were consist ent 
with already known events in T cell stimulation, whereas others corre-
sponded to unknown changes. These include (i) tubulins, which support 
tubulin polymerization from the centrosome at the IS; (ii) the human 
leukocyte antigen complex and different components of CXCR4, known 
to be involved in T cell activation; (iii) heterogeneous nuclear ribonucle-
oproteins; (iv) the CCT chaperone; (v) Hsp90 chaperones and the cdc34 
co-chaperone, which help CCT in the folding of different clients; and (vi) 
the proteasome. These data suggest that the activated centrosomal region 
most likely acts as a specific site for regulation of protein folding and 
degradation. Conversely, there was a coordinated decrease of (i) T cell 
signaling components; (ii) the Rich/Amot polarity complex, involved 
in organization of apical-polarity proteins; (iii) the p-SLP-76 ADAP-Ena– 
Vasodilator- stimulating protein (VASP) complex, implicated in costim-
ulation of T cells; (iv) the WASP-interacting protein, Wiskott-Aldrich 
syndrome protein and myosin IIa (WIP-WASP-myosin IIa) complex, 
participating in IS formation in natural killer cells; and (v) some cyto-
skeletal proteins (septins and dynamins), ribosomes, DNA repair, and 
chromosome structural proteins. An additional functional network anal-
ysis using Cytoscape revealed that the majority of altered proteins formed 
part of dense protein clusters displaying organized expression changes 
(Fig. 1E and fig. S1C).
One of these clusters contained - and -tubulin and tubulin- 
related components, as well as -actin (Fig. 1E), in agreement with 
the SBT results. Both SBT and network analysis indicated a clear 
up-regulation of the eight subunits of the cytosolic chaperonin CCT 
complex. CCT changes in all the replicates are depicted in the bottom 
graph of Fig. 1C. In this CCT-related cluster, -actin and several 
isoforms of  and  tubulins were increased. The tubulin-binding 
cofactor B (TBCB), which helps CCT to maintain tubulin in its cor-
rectly folded conformation (17), also increased in the activated centro-
somal fractions (Fig. 1D). CCT enrichment in fractions corresponding 
to centrosomes from activated T cells was also biochemically corrob-
orated (Fig. 1F). These centrosome modifications were also studied 
in samples from Jurkat lymphoblastoid T cells isolated through a 
more stringent method using nocodazole and cytochalasin D treat-
ment (see fig. S1A) (16). The corresponding centrosomal fractions 
were subjected to tubulin polymerization assays in Xenopus laevis 
egg extracts, showing similar behavior to primary T lymphoblasts 
(fig. S2A). Selected fractions were analyzed for protein content by 
label-free proteomics, which confirmed the enrichment upon activa-
tion of the eight subunits of the CCT complex (fig. S2B and table S3).
CCT localizes at the IS in antigen-driven T-APC contacts (Fig. 1G). 
To assess the role of CCT in the reorganization of the tubulin-based 
cytoskeleton, critical for proper IS formation (20), we simultaneously 
knocked down (KD) four of the eight CCT subunits [siRNAs specif-
ic for the CCT subunits CCT1, CCT2, CCT4, and CCT5 (siCCT); 
and control siRNA (siCtrl) for cells treated with control small inter-
fering RNAs (siRNAs); fig. S3A], specifically those involved in direct 
contact with tubulin and actin during their folding (21) and in 
ATP consumption (22). We studied MT growth by TIRFm, which 
strictly allows visualization of the IS plane, closely apposed to the 
cover glass (Fig. 1, H and I, and movie S1). EB3 (end-binding 3) 
protein binds to the MT plus ends, and its forward and backward 
movements indicate MT growth or shrinking modes, respectively 
(23). The number of tracks emerging from the centrosome area was 
reduced in siCCT-treated cells, as well as the growing speed and 
displacement of the EB3-enriched tips (Fig. 1, H and I).
CCT regulates tubulin dynamics and posttranslational 
modifications at the IS
To determine the mechanism involving CCT activity in the control 
of MT polymerization during IS formation for proper T cell activa-
tion, we analyzed the availability of -tubulin and their posttrans-
lational modifications (PTMs) induced by stimulation of the TCR, 
using native immunoelectrophoresis and specific antibodies against 
total and modified tubulins. Analysis of soluble, native -tubulin 
showed that available heterodimers increased upon activation and 
that CCT silencing induced their accumulation in both resting and 
activating conditions (Fig. 2A), despite the fact that depletion of CCT 
subunits did not cause any change in global actin and tubulin con-
tent, as observed by Western blot (fig. S3A). No clear defects in the 
MT organization in resting cells were detected by immunofluorescence 
(fig. S3B). Tubulin subunits undergo common and distinct PTMs 
upon MT polymerization and depolymerization, which determine 
MT stability and their ability to bind different partners such as MT- 
associated proteins (MAPs) or molecular motors that move cargos 
along them (24). One of these PTMs is detyrosination of -tubulin 
C-terminal EEY into EE [resulting from detyrosination by cytosolic 
carboxypeptidases; 1--tubulin], which increases upon TCR acti-
vation and helps rapid depolymerization due to kinesin 13 binding 
(25). The content of 1--tubulin in soluble heterodimers markedly 
decreased in siCCT cells (Fig. 2B). Together with decreased speed of 
EB3–green fluorescent protein (GFP)–decorated plus tips (Fig. 1, H 
and I), this indicated that heterodimers in siCCT cells were not in-
corporated into MTs long enough to undergo PTMs. Moreover, removal 
of the tyrosine and glutamic acid C-terminal residues (forming 
2--tubulin) paralleled the kinetics of glu--tubulin increase upon TCR 
activation in siCtrl cells but not in siCCT cells (Fig. 2C). We also performed 
these analyses in T cell total lysates under denaturing conditions, which 
do not discriminate between soluble and insoluble tubulins (fig. S3C).
To assess the consequences of the decrease in tubulin polymer-
ization on the organization of the MT network, we analyzed poly- 
glutamylation (pE) of -tubulin, which indicates stabilization of 
polymerized MTs and which increased in siCtrl cells upon activa-
tion (Fig. 2D). The siCCT cells showed higher pE–-tubulin under 
resting conditions, pointing to the presence of highly stabilized MTs 
before TCR stimulation. In addition, acetylation of -tubulin at K40, 
a landmark for MT stabilization, resulted in a similar kinetic to pE 
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Fig. 1. Pericentriolar Systems Biology regulation upon polarized T cell receptor and CD28 activation. (A) Workflow for IS formation, centrosome-enriched fraction 
isolation and in vitro polymerization assay, Western blot, and Erk1/2 activation. (B) Fluorescence from rhodamine–-tubulin and -tubulin. Graph, rhodamine–- tubulin in MTs 
(Ctrl, n = 66; IS, n = 76; Mann-Whitney). (C) iTRAQ (six replicates, 30 donors). Left graphs: Coordinated protein alterations in functional categories at centrosomes during IS. Zqa’ 
values, standardized log2 ratio averages of proteins (stimulated versus control). Right: Global distribution of the eight CCT subunits. Zq < 0, CCTs versus other proteins. BASC, 
super complex of BRCA1-associated proteins. (D) Systems Biology analysis of the six biological replicates showing coordinated increases/decreases. The SBT algorithm was 
applied. (E) Cytoscape map from the SBT analysis. (F) Western blot, centrosome-enriched fractions processed in (B) to (E). Graph, densitometric analysis. (G) CCT5 subunit localization 
in conjugates with APCs (*Raji cells). Scale bars, 10 m. Graph, CCT5 at the IS (means ± SEM, Ctrl n = 23, IS n = 24; Mann-Whitney). (H and I) MT dynamics in activated Jurkat 
cells by TIRFm. (H) Fluorescence images, start point, and maximal projection of the time lapses (t); BF, bright field. Scale bar, 5 m. (I) Imaris-generated track maps. Scale 
bars, 5 m. Graphs, statistics for tracks (median ± interquartile range; n = 15; Mann-Whitney). A.U., arbitrary units; n.s., not significant. *P < 0.05, **P < 0.01, ***P < 0.001.
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after stimulation (Fig. 2E). These results correlated with the lack of 
reorganization of the tubulin cytoskeleton at the IS, as observed using 
MAP7-GFP, a MAP that binds to and stabilizes MTs. Accordingly, 
the organization in siCCT cells of MTs at the IS initially appeared 
disordered, with a clear delay in the centrosome-dependent, radial 
distribution seen in siCtrl cells, as suggested by MAP7-GFP TIRFm 
imaging during IS formation (Fig. 2F and movie S2). Therefore, CCT 
regulates the dynamics of the tubulin network and reduces the growth 
of MTs, thereby inducing a more stabilized MT network.
These data suggest that the processes of synthesis, folding, polym-
erization, and degradation of tubulins are interconnected in T cells 
and is promoted by TCR activation. CCT activity is needed for tubu-
lin folding after its synthesis (26). To ascertain whether the synthesis 
or degradation of proteins affect tubulin polymerization, we assayed 
the effect of lack of synthesis by a short cycloheximide (CHX) treat-
ment (20 g/ml for 40 min) and lack of degradation by bortezomib 
(BTZ) treatment (an inhibitor of the proteasome). We observed a de-
fective incorporation of heterodimers into MTs during T cell activation 
Fig. 2. CCT regulates tubulin dynamics at the IS. (A to C) Native immunoelectrophoresis of -tubulin complexes in resting and activated siCtrl or siCCT Jurkat T cells 
detected with anti–-tubulin (A) and PTMs for 1--tubulin (B) and 2--tubulin (C). (D and E) Native immunoelectrophoresis against total -tubulin (E) and -tubulin 
(D) antibodies, pE-tubulin (D), and acetylated K40 -tubulin (E). n = 3. (F) Analysis of MT dynamics in activated Jurkat T cells cotransfected with MAP7-GFP and siCtrl or 
siCCT by TIRFm; n = 3. Scale bars, 5 m. (G) Cells transfected with EB3-RFP were treated or not with cycloheximide (CHX) for 40 min and allowed to spread over a stimulating 
surface before TIRFm analysis. Imaris track analysis is shown (15 s; n = 16, siCtrl and CHX; Mann-Whitney). (H) Cells stably expressing low amounts of EB3-GFP were treated 
or not with bortezomib (BTZ; 520 nM) for 2 hours and allowed to spread over a stimulating surface before TIRFm analysis. Imaris track analysis is shown (30 s; Ctrl n = 15, 
BTZ n = 14; Mann-Whitney). (I and J) Native immunoelectrophoresis of -tubulin complexes in resting and activated T cells treated with CHX (I) or BTZ (J) detected with 
anti–-tubulin. n = 3, at least. Numbers correspond to normalized (Ctrl) densitometry analysis (Image Gauge software). *P < 0.05, **P < 0.01, ***P < 0.001.
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with CHX, whereas BTZ increased polymerization, as observed by 
EB3 tracking using TIRFm (Fig. 2, G and H, and movies S3 and S4). 
We used low-expressing EB3 cells to assess the BTZ effect. The content 
in native -tubulin increased with CHX treatment (Fig. 2I) but was 
reduced with BTZ (Fig. 2J), which supports the notion that tubulin 
dynamics is regulated by synthesis and degradation balance.
3D cellular ultrastructure depends on CCT polarized activity
To address the mechanistic role of CCT in IS formation, we imaged 
resting and stimulated human primary CD4 T cells using cryo-SXT, 
which allows direct visualization of thick specimens (up to 10 m) 
upon vitrification and their 3D reconstruction in the 50-nm resolution 
range (27). Primary CD4 T cells from healthy donors were treated 
with control siRNA (siCtrl) or siRNA specific for the CCT subunits 
(siCCT), cotransfected with EB3-GFP and stained for MitoTracker 
Orange upon sorting for GFP for correlative cryo-microscopy (silenc-
ing is shown in fig. S4A and movies S5 to S8). The 3D reconstruction 
of whole cells allowed us to locate, through calculation of different 
parameters, the position of centrioles within the centrosome and with 
respect to the adhering surface (Figs. 3 and 4, A and B, and fig. S4B). 
First, the area of influence of the centrosome (AIC), which shows a 
different appearance from the rest of the cytoplasm and includes 
the PCM, the adjacent Golgi cisternae and the associated vesicular 
network, was assessed as a unique entity. The median AIC volume 
showed a tendency to increase upon stimulation in siCtrl cells (Fig. 4B). 
TCR activation did not affect centriole size, without apparent change 
in length (L) or radius (r); the distance (d) between the centers of 
the centrioles remained basically invariant (fig. S4B). Activation of 
TCR induced a decreased angle (a) between the centrioles in siCtrl 
cells but not in siCCT cells (from around 68° to around 29° in siCtrl 
cells; Fig. 4C). The centriole pair in siCtrl cells showed a tendency to 
adopt a parallel orientation with respect to the plane of the IS, which 
changed markedly upon activation, although CCT KD reverted this 
change (angle , Fig. 4D). Both siCtrl and siCCT centrosomes showed 
little or no change in their coplanar distribution upon stimulation 
(angle A, Fig. 4E). The centrosome polarized at the IS upon TCR 
activation in the majority of cells analyzed [about 70 to 80% either 
in mouse or human cells; (2, 4)]. However, part of them was not 
located at the IS. We observed that the EB3-decorated tracks emerging 
from the centrosome are directed toward the IS, although the cen-
trosome is not near the IS (Fig. 4F and movie S9). We propose that 
the specific disposition of the centrioles inside the centrosome and 
the orientation of the centriole pair with respect to the IS are re-
sponsible for this effect (Fig. 4G). The MT stabilization induced by 
CCT KD probably prevents the changes induced in the centriole pair 
by TCR activation in siCCT cells. This may also affect the arrange-
ment of the mitochondrial network, which does not change its aver-
age volume (fig. S4C), although mitochondria undergo changes in 
their individual radius. The mitochondria of siCCT cells show a de-
creased radius, which increases with activation, whereas the control 
cells show a tendency to reduce their radius upon 15 min of activa-
tion (fig. S4D). Cell viability was not affected by siCCT KD (fig. S4E).
CCT KD prevents correct centrosomal orientation, which is also 
observed for the Golgi apparatus (GA). In siCtrl cells, the GA orga-
nized around the centrosome and was localized near the IS, as im-
aged by STED microscopy. siCCT cells also showed the GA around 
the centrosome, but it was partially polarized and displayed a differ-
ent orientation of the cisternae (fig. S5, A to C). In contrast, T cell 
actin–based frontal lamella contacting the APC seemed unaffected 
by CCT depletion, as observed by STED microscopy (fig. S5, B and 
C). Moreover, phosphorylation of the myosin light chain was not 
affected by siCCT upon TCR activation (fig. S5D).
CCT regulates signaling at the IS and nanovesicle dynamics
The intracellular traffic at the IS sustains TCR signaling and requires 
a correct centrosome function (2, 20). We observed a decreased sig-
naling in siCCT cells, as determined by reduced phosphorylation of 
CD3 (Y83), LAT (Y132), and PLC1 (Y783) (Fig. 5A). We also stud-
ied Nuclear factor for activated T cells (NFAT) dephosphorylation 
in response to the TCR-dependent increase in calcium flow, which 
was reduced in siCCT cells (Fig. 5B). Nuclear factor B (NFB) 
phosphorylation showed a tendency to decrease in siCCT cells, 
pointing to defects in these signaling pathways. To ascertain the 
organization of TCR/CD3 complexes at the IS surface, we assessed 
CD3 clustering through confocal microscopy. siCCT cells were less 
efficient in forming the CD3 central cluster (Fig. 5C). However, 
this effect was not due to defective surface expression of CD3 in the 
T cells, as assessed by flow cytometry (Fig. 5D). We therefore analyzed 
the nanovesicle trafficking beneath the plasma membrane at the IS, 
to ascertain its possible contribution to this defect. Jurkat cells 
cotransfected with both EB3-GFP and CD3- mCherry along with 
siCCT showed a reduction in the number and speed of CD3-bearing 
vesicles (albeit with increased duration). Their trajectories followed a 
more peripheral circuit rather than localizing at the center of the IS 
(Fig. 5E and movie S10), therefore suggesting a defect in their con-
tribution to signaling at the IS as repositories of signaling molecules 
and/or by directly spreading the TCR/CD3 signaling (20).
CCT regulates mitochondrial positioning and function
Since mitochondria are known to polarize toward the IS in an MT- 
dependent manner and to sustain local calcium increases (10, 11), 
we assessed their localization and function. siCCT cells also showed 
defects in normal mitochondria polarization and fragmentation at 
the IS, as illustrated by MAP7-GFP relative localization under TIRFm 
(Fig. 6A and movies S11 and S12). STED imaging of whole cells con-
firmed these results (Fig. 6B and movies S13 and S14), corresponding 
to a defective movement if mitochondrial fission is defective (10). 
The mitochondrial mass was not affected (Fig. 6C and fig. S6, A and 
B). This is in accordance with a lack of response of mitochondria in 
terms of membrane depolarization (Fig. 6D) and a concomitant de-
crease in ATP production upon activation (measured fold induction 
of 1.514 ± 0.069 in siCtrl versus 1.399 ± 0.102 in siCCT, means ± SEM; 
Fig. 6E). The basal mitochondrial respiration of siCCT cells was 
similar to control cells, whereas the increase in respiration [oxygen 
consumption rate (OCR)] observed upon T cell activation was lower 
in siCCT cells, as was their maximal respiration rate (Fig. 6F and 
table S4). Also, the extracellular acidification rate (ECAR), an indi-
cator of glycolysis, was similar under basal conditions for siCtrl and 
siCCT cells and showed a parallel decrease in activated siCCT cells 
(Fig. 6F). The analysis of the mean fluorescence intensity of living 
T cells TIRFm also revealed that mitochondria were less active at the 
IS in siCCT cells (Fig. 6G and movie S15). Video microscopy imag-
ing of Jurkat-Raji conjugates showed that CCT silencing caused 
mislocalization of mitochondria from the IS area (Fig. 6H and movies 
S16 and S17). These data support the role of CCT in regulating T cell 
metabolism during T cell activation.
Mamalian Target of rapamycin complex 1 (mTORC1)–associated 
signaling, a marker for immune metabolic status, was defective in 
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siCCT cells, accompanied by a decreased phosphorylation of the S6 
ribosomal subunit in human primary CD4 T cells (Fig. 6I and fig. S6A) 
and in Jurkat T cells (fig. S6C), which supports a decrease in protein 
synthesis. Recent evidence has shown that CCT assists LS8 and Raptor 
(Regulatory-associated protein of TOR) folding, two subunits of the 
mTOR complex, therefore forming a feedback loop between TCR 
activation, protein synthesis, and tubulin dynamics (28). On the other 
hand, the mTOR complex is known to associate to the lysosomes upon 
activation (29); we therefore analyzed the localization of lysosome- 
associated membrane protein 1 (LAMP1)–positive vesicles in siCCT cells 
during IS formation, finding a defect in their accumulation around the 
centrosome upon TCR-dependent polarization (Fig. 6J). Interleukin-2 
(IL-2) production, a late activation marker needed for T cell prolifera-
tion, decreased in siCCT cells stimulated by Staphylococcus enterotoxin-E 
(SEE)–pulsed APCs (Fig. 6K). Cells silenced for individual CCT 
subunits showed a similar decrease in IL-2 secretion (fig. S6, D and E). 
In contrast, CD69 surface expression, an early activation marker, was 
similar in both siCtrl and siCCT cells (fig. S6, F and G), suggesting that 
cells sense the activation through the TCR although incompletely. 
These data indicate that upon polarizing stimulus, CCT is required to 
control the 3D orientation of centrioles and to organize correct MT 
growth and organization, facilitating changes in the centrosome that 
will allow correct cell polarity and activation.
DISCUSSION
Our data provide experimental evidence about the important role 
of the cytosolic chaperonin CCT in dynamic centriolar maturation 
Fig. 3. CCT regulates the 3D T cell organization at synaptic contacts. 3D reconstructions of cryo-SXT images showing resting (Ctrl) and IS-forming (IS) human primary 
CD4 T cells, treated with control siRNA (siCtrl) or siRNAs for CCT (siCCT). Blue, nucleus; transparent grid, plasma membrane; red, mitochondria; green, centrioles; white, 
vesicles; olive, lipid droplets (colors may change due to superposition of the nucleus). Asterisks indicate same corner for the two views. Insets: Slices of the reconstructed 
cryo-SXT imaging. N, nucleus; m, mitochondria. Scale bars, 500 nm. The size of the squares indicating the carbon surface is 5 m.
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and cell polarization upon TCR activation and costimulation through 
CD28. We propose a mechanism involving the “de novo” synthesis 
of tubulin to sustain MT dynamics early upon T cell activation. This 
synthesis requires the correct folding of tubulin, which is assisted by 
CCT and maintained by tubulin-binding cofactors.
Here, we have used deep quantitative proteomics and Systems 
Biology to study the changes in human primary T cell centrosome 
composition that occur after stimulation and IS formation, avoid-
ing pretreatment of cells with drugs targeting the cytoskeleton before 
TCR stimulation (15, 16, 30) to favor full T cell activation (8). In our 
Fig. 4. CCT regulates the 3D centriolar organization at synaptic contacts. (A) Gallery of CD4 T cells 3D reconstructed after cryo-SXT. Mitochondria are shown in red, 
centrioles in green, vesicles in white, and lipid droplets in yellow. The right images correspond to a section of the area of AIC, including the centrioles (thin arrows: longi-
tudinal section and wide arrows, cross section). Scale bar, 500 nm. (B) Volume of the AIC. (C) Centrosome internal angle (a). (D) Angle (A) between the vector joining the 
center of mass of each centriole and the IS plane. (E) Angle () between the centriolar cross-vector and the IS plane. Graphs, median and interquartile range. Blue dots, 
mean (n = 12, control siCtrl; n = 12, control siCCT; n = 9 IS siCtrl; n = 8, IS siCCT). (F) Resonant scanner confocal videomicroscopy of whole cells showing growing MT tips 
toward the IS. (G) Model for centriolar and centrosomal disposition respect to the IS plane in resting (Ctrl) and TCR-stimulated T cells (IS).
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experimental settings, the timing of activation corresponded to early 
T cell activation, concomitant with cytoskeleton remodeling and cen-
trosome translocation toward the IS (15 to 20 min). At this stage, intra-
cellular transport based on MT-dependent vesicular traffic to and from 
the IS is already established (9, 31). We observed upon T cell activation 
a coordinated increase of CCT, Hsp90 and its co-chaperone Cdc34, 
a number of tubulin  and  isoforms, actin and TBCB in the centrosome- 
enriched fractions. We therefore analyzed the role of CCT in T cell 
activation. Mutations in isolated CCT subunits have implications for 
cell growth and gene expression, with different effects among differ-
ent subunits in yeast (32). To avoid complications, we simultaneously 
silenced four of the eight CCT subunits, specifically those involved 
in direct contact with tubulin and actin during their folding (21, 33), and 
in ATP consumption (22, 34, 35). The silenced T cells (siCCT-treated 
cells) did not correctly polymerize MTs from the centrosome, as sim-
ulated upon treatment with CHX, an inhibitor of protein synthesis.
Fig. 5. CCT regulation of tubulin dynamics is required for TCR signaling and IS formation. (A) TCR downstream signaling of siCtrl- and siCCT-treated Jurkat T cells 
during activation: pY83-CD3, pY132-LAT and pY783-PLC1. Total proteins, loading controls. Graphs, means ± SEM; n = 5. Two-way ANOVA. (B) NFATc2 and pS468-NFB 
in primary human CD4 T cells. Graphs, means ± SEM. n = 3 and 4. One-way ANOVA. (C) CD3 distribution at the IS in Jurkat T cells during synapse; a maximal projection of 
CD3 is shown, merged with bright-field (BF) image; 3D reconstruction was performed with Leica LASX. Scale bar, 5 m. Graph, CD3 ratio at the IS by “synapse measures” 
algorithm. Mean and SD. One-way ANOVA [n = 63 (siCtrl Ctrl), 47 (siCCT Ctrl), 127 (siCtrl IS), and 156 (siCCT IS) from three independent experiments]. (D) CD3 surface 
expression in human primary CD4 and Jurkat T cells (n = 4 and 3, respectively). (E) CD3-bearing vesicle dynamics in activated T cells by TIRFm as in Fig. 1 (H and I). Scale 
bars, 10 m. Imaris track maps and statistical analysis are shown (30 s; median plus interquartile range; Mann-Whitney test; n = 30). Scale bars, 5 m. **P < 0.01; *P < 0.05.
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Fig. 6. CCT regulation of tubulin dynamics controls mitochondrial and metabolic tuning during IS formation. (A) Mitochondrial dynamics at the IS. Fluorescence 
(TIRFm) and bright-field (BF) images. Blue boxes, magnification of the insets (scale bars, 5 m; n = 4). (B) STED 3D reconstruction of siCtrl and siCCT cells forming IS 
(45 min). Scale, distance to IS. Scale bar, 5 m; n = 3. (C) Mitochondrial mass (n = 8). (D) Normalized ratio of mitochondrial membrane potential () to total mitochondrial 
mass during IS. (E) ATP production during IS (n = 4; Mann-Whitney). (F) Mitochondrial respiration during IS (n = 4). (G) Mean fluorescence intensity (MFI) from IS-forming 
cells by TIRFm (Mitotracker Orange; frame lapse, 5 s; n = 3). (H) Mitochondrial localization at the IS (dotted lines, SEE-pulsed APCs). Scale bar, 10 m. (I) mTORC1 signaling 
in human CD4 T cells. Graphs, normalized fold-induction ratios. Means ± SEM; one-way ANOVA (n = 4). (J) LAMP1+ vesicles in siCtrl and siCCT human CD4 T cells. Flu-
orescence maximal projection and BF merged image showing control or stimulating beads. Scale bar, 5 m. Graph, LAMP1+ distance to the centrosome [n = 36 (siCtrl-Ctrl), 
37 (siCCT-Ctrl), 40 (siCtrl-IS), and 43 (siCCT-IS); three donors; mean ± SD]; one-way ANOVA. (K) IL-2 production from siCtrl and siCCT cells (n = 4; one-way ANOVA; **P < 0.01; 
****P < 0.0001).
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The role of the centrosome in mitosis and the establishment of 
polarity during development is well known (36), and its components 
have been analyzed by different means including biochemical isola-
tion and Western blot, immunofluorescence, and proteomics (16, 36, 37). 
In T cells, centrosome polarization and its tubulin-nucleating activ-
ity constitute important processes that lend support to specific T cell 
activation (2, 20), thus allowing progression of adaptive immune 
responses. Because of the relevance of this process, we analyzed the 
structural organization of the IS in control and CCT KD human 
primary CD4 T cells from peripheral blood using a noninvasive ap-
proach. Whole cells were vitrified and subjected to cryo-SXT to gen-
erate a 3D view without any fixative, stain, or mechanical slicing, at 
a higher resolution than any optical microscopy (38). Our results 
allowed us to parameterize the localization and arrangement of the 
centrosome and centrioles at a nanometric resolution. siCCT-treated 
cells did not organize the area surrounding the centrosome (what 
we have termed AIC) and the IS, although they formed an actin lamella 
at the area of adhesion and polarized the centrosome.
cryo-SXT, STED, and TIRFm data showed that, although cell 
adhesion was conserved and cortical actin remained arranged in the 
characteristic lamella organized around the APC, tubulin polymer-
ization from the centrosome was clearly disrupted after CCT KD. 
-Tubulin polymerization increased in activated T cells, so the ob-
served rise in the proportion of soluble heterodimers would be expected 
to sustain increased MT growth upon TCR activation. Nevertheless, 
the observed accumulation of heterodimers in CCT KD cells does 
not correspond with this notion. Differences in the PTM of these 
heterodimers upon T cell activation, altered in siCCT-treated cells, 
are probably the basis of the defect in tubulin polymerization. The 
detected lack of detyrosinated (1) and 2 PTMs in the soluble hetero-
dimers from siCCT cells supports that these PTMs control tubulin 
polymerization. Tyrosinated -tubulin is the nonprocessed protein, 
which allows rapid MT depolymerization after its incorporation 
(25). This is prevented by detyrosination of -tubulin by a carboxi-
peptidase (39), resulting 1--tubulin (glutamylated--tubulin), which 
is observed upon T cell activation [here and (40)]. It seems that de-
tyrosination occurs in the polymerized MTs, allowing low rates of 
depolymerization. The conversion of -tubulin into 2--tubulin 
has been linked to the degradation of the protein due to the nonre-
versible nature of this PTM; 2--tubulin accumulates in long-lived, 
very stable MTs but cannot be tyrosinated by the tubulin-tyrosine 
ligase as 1--tubulin is (41). The incorporation may have been 
short-lasting due to active MT depolymerization when CCT is not 
available to actively fold newly synthesized tubulin, since CCT ac-
tivity is needed for tubulin folding after synthesis of the protein (26). 
Consistent with this, we reproduced a similar accumulation by inhi-
bition of polysome-dependent ribosomal synthesis of tubulin by CHX 
treatment at short times (42), which also prevented MT growth. 
Conversely, we also observed that BTZ treatment induced the de-
crease in soluble heterodimers, accompanied by increased tubulin 
polymerization at the IS. The chronic inhibition of the proteasome 
through BTZ induces MT polymerization in other systems (43). There-
fore, CCT accumulated in the AIC to assist in MT polymerization 
during the induced tubulin synthesis after TCR activation and its 
function seems to be coordinated with the proteasome, which is 
also accumulated at the AIC. The subcellular localization of CCT 
may represent a mechanism to control its folding activity through 
the availability of client proteins and co-chaperones. It is conceiv-
able that heterodimers bearing specific PTMs such as acetylation or 
pE do not incorporate correctly into MTs. The increase in pE tubu-
lins and acetylated (AcK40) -tubulin reflects the altered MT dynam-
ics in CCT KD cells. These are markers of MT stability (24), which 
were higher during resting state in CCT-deficient cells, the opposite 
of what was observed in control cells. Furthermore, T cell activation 
did not increase these PTMs in CCT KD cells, an observation sup-
ported by the altered binding of MAP7 to the MT network at the 
IS. The MT network in CCT KD T cells was “frozen” upon activa-
tion, which probably affected their ability to correctly mature their 
centrosomes. All this is in agreement with the altered response of 
the centrioles in activated siCCT-treated cells, with differential in-
tracentrosomal disposition, with no changes in their relative angle. 
The centrosome localization relative to the IS plane was altered in 
stimulated cells by the deficiency in CCT activity, which may have 
prevented proper MT organization at the IS, as observed in live-cell 
TIRFm experiments. In control cells, the centrosome and associated 
GA and secretory apparatus were in close apposition to the APC.
The localization and arrangement of the centrosome is proposed 
to be an important factor for asymmetric division in T cells upon 
cognate TCR-mediated stimulation, necessary for the differentiation 
of naïve T cells into effector and memory T cells (44). However, 
when CCT subunits were silenced, the centrosome mislocalized and 
did not properly move toward the IS. This was associated with de-
fects in the dynamics of tubulin polymerization and MT growth and 
in the efficient transit between the centrosomal area and the IS, which 
impaired the movement of CD3-bearing signaling nanovesicles. 
Hence, the role of CCT in IS formation is related to the cytoskeleton 
network organization. The PCM-localized endosomes were, conceiv-
ably, the specific accumulation place of proteasome subunits, chap-
erones, and Rabs (Ras-associated binding proteins) for organelles 
with a relevant role in T cell activation and recycling of cell compo-
nents. Observation of regulatory proteins of intracellular traffic in 
the centrosome-enriched fractions points to this location as an im-
portant hub for triage between folding and degradation at the IS. 
The influence of inhibitors of protein synthesis and degradation 
(proteasome) in tubulin dynamics supports the coordination between 
cell reorganization, transport, synthesis, and degradation upon TCR 
activation at the AIC. The dynamics of the centrosome at the IS 
were clearly altered when CCT activity was silenced, and the subse-
quent localization and movement of CD3-bearing vesicles at the IS 
were also abolished. These events prevented the correct clustering 
of TCR/CD3 complex at the plasma membrane, with less protein 
observed. Moreover, the polarization of LAMP1+ vesicles was also 
impaired. Vesicle trafficking is dependent on MT-based intracellular 
transport (20), and defects prevent full T cell activation, as observed 
in CCT KD cells.
Our data show that CCT is needed for normal shape, size, and 
localization of mitochondria at the IS. In CCT KD cells, mitochon-
dria were defective in their capacity to depolarize their membrane 
by dropping membrane potential, which is essential for correct T cell 
response and metabolic status. This was further corroborated by our 
observations that siCCT cells show a reduced OCR (an indicator of 
oxidative phosphorylation), a reduced ECAR (an indicator of gly-
colysis), and reduced ATP production upon T cell activation. There-
fore, to sustain their metabolic status during activation, T cells require 
CCT. The calcium-dependent pathways seem to be affected by this 
delocalization, as observed by the decreased activation of NFATc2, 
corresponding to their described role in sustaining calcium flow at 
the IS (11). The mTOR complex, which is involved in mitochondrial 
Martin-Cofreces et al., Sci. Adv. 2020; 6 : eabb7242     2 December 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
11 of 17
activation, lysosome function, and ribosomal synthesis (45), remained 
poorly active upon TCR stimulation in CCT KD cells, preventing 
phosphorylation and activation of the S6 ribosomal component, in-
dicating a defective ribosomal activation. Therefore, there is a lack 
of protein synthesis in these cells upon activation, which is supported 
by the effect of inhibition through CHX, mimicking the CCT effect. 
Since this chaperone is in charge of folding mLST8 and Raptor, two 
members of the mTOR complex (28), a coordinated action of CCT 
during TCR activation would be required during IS formation to 
allow protein synthesis induction and folding of de novo proteins. 
Hence, CCT activity determines the polarization capacity of T cells 
during IS formation and is required to organize and allow correct 
function of the organelles for proper T cell activation.
In summary, we report herein, using different structural and bio-
chemical techniques, changes in the 3D ultrastructure of the centro-
some and the protein composition during IS formation in human 
primary CD4 T cells. We found that the metabolic status of activated 
T cells is dependent on this chaperone, which assists in protein syn-
thesis and folding induced by TCR activation, directly intervening 
in the ability of tubulin to be incorporated and retained into MTs. 
These changes control and determine the organization and func-
tionality of organelles such as mitochondria and are dependent on 
the chaperone CCT, which is enriched in activated centrosomes. 
We propose that this mechanism is relevant for biological processes 




For experimentation performed in this work, we initially used an 
already known sample size that was previously used in other works 
for similar techniques, although performed with samples from dif-
ferent organisms or cells. The experiments with human primary cells 
were performed with the number of different donors needed to have 
enough biological material to perform the required techniques (bio-
chemical extraction of samples, proteomic studies, cryo-soft x-ray 
microscopy, and flow cytometry). The experimental results obtained 
allowed the investigators to determine that the sample size was cor-
rect. Data exclusions. In general, there has not been data exclusion 
during the analysis of data. For proteomic and microscopic analysis, 
specific information is provided along individual sections here in 
Methods. Replication. The main conclusions and data obtained in 
this work have been replicated in different laboratories and investi-
gators participating in this study; the results have been corroborated 
with cell lines and primary cultures. Randomization. Samples were 
homogeneously divided into the experimental groups in a random 
form for the different experiments performed (different kind of cells, 
primary or cell lines, were always isolated and cultured in parallel, 
treated similarly, and used in comparable experimental conditions). 
Blinding. Cells and samples were always treated and analyzed simi-
larly, independently of their origin or category. Blinding of samples 
was not routinely performed but was randomly executed during 
different repetitions of experimentation (microscopy and pro-
teomics), since investigators performing the different steps of experi-
ments, such as biochemical extractions, Western blotting, microscopic 
analysis, or proteomic studies did not inform each other about the 
numbering/categories of samples until the end of the experimental 
repetition.
Antibodies and reagents
The source of commercial antibodies was as follows: anti-human 
CD3 clone HIT3a monoclonal antibody (mAb) (BioLegend); T538 
Protein kinase C (PKC-), Y783 PLC1, PLC1, pS2448 mTOR, mTOR, 
pS235-S236 S6, S6 ribosomal subunit, pS468 NFB, pS402Y404 Erk1/2, 
Erk 1/2 rabbit antibodies (Cell Signaling Technology); Protein kinase C 
(PKC), myosin light chain (MLC), purified mouse anti-human CD28, and 
anti-p150 Glued mAbs (BD Biosciences); -actin AC-15 clone, anti–-tubulin 
GTU88 clone, anti–-tubulin DM1A clone, anti–-tubulin–fluorescein 
isothiocyanate (FITC) DM1A clone, and anti-K40Acetyl–-tubulin 
12B4 clone mAbs (Sigma-Aldrich); rabbit anti-LAT and rabbit anti- 
Tom20 antibodies (Santa Cruz Biotechnology); anti-phosphoY132 
LAT, rat anti-CCT1, rabbit anti-CCT4, rabbit anti-CCT5, rabbit 
anti-giantin, and chicken anti-GFP antibodies (Abcam); golgin-97 mAb 
(Life Technologies) and goat anti-mouse H&L chain–specific immuno-
globulin G and mouse anti-CCT2 antibodies (Merck Millipore); anti- 
human CD28-PE, anti-LAMP1–Alexa Fluor 647, anti-human CD4 V450, 
anti-human CD8 V500, anti-human CD3-Allophycoerythrine, anti-human 
CD45RA, anti-human HLA DR-Peridinin Chlorophyll Protein, 
anti-human CD11a-Biotin, anti-human CD11a-allophycocyanin, 
anti-human CD69-allophycocyanin, and anti-human CD3-PE (BD 
Biosciences); anti-human CD3 FITC and isotype control–FITC 
(Immunostep); anti-pS19 MLC (Rockland Antibodies). Alexa Fluor 647 
and Alexa Fluor 568 conjugated phalloidin, MitoTracker Orange 
and CMAC probes, Alexa Fluor 488 conjugated anti-chicken, highly 
cross–adsorbed Alexa Fluor 647 and Alexa Fluor 568 conjugated 
anti-rabbit, and Alexa Fluor 488 conjugated anti-mouse antibodies 
were from Molecular Probes, Invitrogen, and Thermo Fisher Scientific. 
The rabbit anti- CD3 448 antibody was a gift from B. Alarcón [Centro 
de Biología Molecular “Severo Ochoa” (CBMSO), Madrid, Spain]. 
The rabbit anti-NFATc2 antibody was a gift from J. M. Redondo 
[Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 
Spain]. Mouse monoclonal antibody clone T3b anti-human CD3 
was produced at the Immunology Department (Hospital Princesa, 
Madrid). Rabbit antibodies for tubulin PTMs pE-tubulin, 1- and 
2--tubulin, and mouse anti–-tubulin 12G10 clone and -tubulin 
E7 clone were generated by I. Vernos. Anti-TBC polyclonal anti-
bodies were generated by J. C. Zabala.
Cell lines
The Raji lymphoblastoid B and Jurkat E1-6 cell lines were grown in 
RPMI 1640 medium (Gibco) supplemented with 5% fetal bovine 
serum (FBS). The following reagents were obtained through the Na-
tional Institutes of Health (NIH) AIDS Reagent Program, Division 
of AIDS, National Institute of Allergy and Infectious Diseases, NIH: 
Raji from L. Wu and V. N. KewalRaman and Jurkat from A. Weiss. 
Medium for CH7C17 Jurkat T cells stably expressing TCRv3 spe-
cific for a peptide from influenza hemagglutinin (HA) was supple-
mented with hygromycin (400 g/ml) and puromycin (4 g/ml) 
(Invivogen). Geneticin-418 (0.4 mg/ml; Invivogen) was added for 
culturing CH7C17 T cells stably transfected with MAP7-GFP, EB3-GFP, 
and EB3-RFP constructs [EB3 constructs were from A. Akhmanova 
(Utrecht University, Netherlands)]. Both Raji and Jurkat cells come 
from NIH AIDS Reagent Program and show XY genotype.
Primary human lymphocytes
For isolation of CD4 T cells or T lymphoblast cultures, human pe-
ripheral blood mononuclear cells (PBMCs) were isolated from buffy 
coats from healthy donors [provided by “Centro de Transfusiones 
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de la Comunidad de Madrid” under an agreement with the Hospital 
Princesa (Madrid) and approved by the CEIm of Hospital Princesa, 
according to government ethical consent] through separation on a 
Biocoll gradient (Biochrom). Nonadherent cells were collected after 
plating PBMCs at 37°C. CD4 T cells for synchrotron experiments 
were isolated with a Miltenyi Biotec negative isolation kit or with a 
STEMCELL negative isolation kit and used for subsequent procedures. 
Peripheral blood lymphocytes obtained after adhesion steps were 
cultured for 48 hours in the presence of SEE (0.01 g/ml; Toxin 
Technology) to induce lymphocyte proliferation, and IL-2 (50 U/ml) 
was added to the culture medium every 2 days until use. Further 
information and requests for resources and reagents should be di-
rected to and will be fulfilled by corresponding authors.
Cell transfection
CH7C17 or E1-6 Jurkat T cells (1.5 × 107) were transfected with 1.2 M of 
each siRNA to a total 5 M and 3.5 g of plasmid using the Gene Pulser II 
(Bio-Rad) at 240 V and 975 F, and cells were analyzed 48 hours after 
transfection. Primary CD4 T cells were nucleofected with Amaxa I in 
Opti-MEM I (Gibco, Invitrogen) using U-04 program after a heat-shock 
step with HBSS (Hank’s buffered salt solution). Cells were cultured for 
48 hours in RPMI 1640 supplemented with 10% FBS and IL-7 (10 ng/ml).
T cell activation, cell lysis, SDS- and native-PAGE, 
and immunoblotting
For human TCR stimulation, T cells were incubated for the indicated 
times with latex microbeads (6.4 m in diameter) conjugated to anti- 
CD3 mAb (5 g/ml) and anti-CD28 mAb (1.66 g/ml). Cells were 
activated with anti-CD3 + anti-CD28–coated beads to avoid the 
presence of tubulin from APCs in the cell lysates. T cells were incu-
bated for the indicated times allowing them to spread over surfaces 
coated with anti-CD3 mAb (5 g/ml) and anti-CD28 mAb (1.66 g/ml). 
For antigen stimulation, Raji cells were pulsed with SEE (0.3 g/ml, 
30 min) and mixed with Jurkat cells (1:10); alternatively, Hom2 cells 
pulsed with HA peptide (200 g/ml, 2 hours) or with SEB (5 g/ml, 
30 min) were mixed with CH7C17 cells (1:10) in HBSS. Where in-
dicated, cells were pretreated with BTZ (520 nM, 2 hours; Calbiochem), 
CHX (20 g/ml, 40 min; Sigma-Aldrich), or vehicle at 37°C in HBSS 
before stimulation. For SDS–polyacrylamide gel electrophoresis 
(PAGE), cells were lysed in 20 mM tris-HCl (pH 7.5) containing 1% 
NP-40, 0.2% Triton X-100, 150 mM NaCl, 2 mM EDTA, 1.5 mM 
MgCl2, and phosphatase and protease inhibitors. Lysates were spun 
at 1000g (4°C, 10 min) to remove debris and nuclei. Proteins were 
resolved by SDS-PAGE and transferred to nitrocellulose membranes. 
For NFAT analysis, 6% polyacrylamide gels containing 1 mM EGTA 
were used. After blocking with tris-buffered saline (TBS) containing 
0.2% Tween and 5% bovine serum albumin (BSA), membranes were 
blotted with primary antibodies (overnight at 4°C) and peroxidase- 
labeled secondary antibodies (30 min) and detected with the 
ImageQuant LAS-4000 chemiluminescence and fluorescence imag-
ing system (Fujifilm). For native-PAGE assays of protein complexes, 
cells were resuspended in 0.1 MES (pH 6.7) containing 1 mM EGTA, 
1 mM MgCl2, 10 mM guanosine 5′-triphosphate (GTP), inhibitors 
of proteases and phosphatases, lysed through a 2-ml dounce homog-
enizer (20 strokes; tight pestle) at room temperature and centrifuged 
at 14,000g at 25°C for 30 min. Protein content in supernatants was 
determined by Bradford assay, and native electrophoresis was per-
formed for 2 hours at 80 V in MES buffer containing 1 mM MgCl2, 
1 mM EGTA, and 1 mM GTP. Samples were run in triplicate with 
20 g loaded per sample and transferred to nitrocellulose mem-
branes for 2 hours at 400 mA in tris-Gly solution. Blots were probed 
against the indicated antibodies; anti-TBCs were used at 1:1500, an-
ti-tubulins at 1:10,000, and anti-PTMs at 1:2000 (46).
Centrosome-enriched subcellular fraction isolation
Primary human T lymphoblasts were stimulated with anti-CD3 + 
anti-CD28–coated beads for 20 min, ice-cooled, and centrifuged at 
2,000g at 25°C for 30 min. Cells were washed in TBS and resuspended 
in lysis buffer (2 × 106 cells/ml) 1 mM tris-HCl (pH 7.4) containing 
0.5% NP-40, 0.5 M MgCl2, 0.1% -mercaptoethanol, and inhibitors 
of proteases and phosphatases for 10 min with gentle shaking. Lysates 
were filtered through a nylon mesh and centrifuged at 24,000g with 
inhibitors for 10 min at 4°C. The supernatant was filtered again to re- 
equilibrate it into a final 10 mM piperazine-N,N′-bis(2-ethanesulfonic 
acid) (PIPES) (pH 7.2) and then centrifuged to pellet the centrosomes 
(24,000g at 4°C for 60 min). The pellet was resuspended in 10 ml of gradient 
buffer [10 mM PIPES (pH 7.2), 5% sucrose, 0.1% -mercaptoethanol, 
and 0.1% Triton X-100] and homogenized through 21-gauge (two 
times) and 25-gauge (three times) needles before loading onto the 
first sucrose gradient [1 ml 70%, 2 ml 50%, 2 ml 40%, 2 ml 30%, and 
2 ml 20% (w/w)]. The gradient was subjected to a 32,500g centrifu-
gation for 1 hour at 4°C in an SW28 rotor. Fractions from 50 to 70% 
were collected, mixed, diluted with gradient buffer to a final con-
centration of about 20 to 30% of sucrose and loaded onto a second 
sucrose gradient [0.5 ml 70%, 0.5 ml 50%, and 1 ml 40% (w/w)]. The 
gradient was centrifuged at 130,000g for 1 hour at 4°C in an SW40 
Ti rotor, and fractions were then recovered and analyzed for -tubulin 
content by Western blot and immunofluorescence and for in vitro 
tubulin polymerization ability. Centrosome-enriched fractions from 
Jurkat T cells were isolated as described (16) in similar resting and 
activation conditions to the primary T lymphoblasts and analyzed 
as above to determine -tubulin–enriched fractions. Proteomic anal-
ysis was performed from equivalent enriched fractions.
In vitro polymerization of tubulin
Rhodamine-conjugated -tubulin and nonlabeled -tubulin were re-
suspended in 80 mM PIPES buffer (pH 6.9) containing 1 mM MgCl2, 
1 mM EGTA, 5% glycerol, and 1 mM GTP. Dissolved tubulins were stored 
at 5 mg/ml and mixed 1:5 for polymerization (2.86 mg/ml, 10 l) with 
centrosome fractions (2.5 l) and 5 l of buffer. Tubes were heated at 37°C 
for 20 min, and reactions were stopped by glutaraldehyde fixation (1%) for 
5 min at 37°C. Samples were then diluted in 80 mM PIPES buffer (pH 6.9) 
containing 10 M taxol, 1 mM MgCl2, and 1 mM EGTA for additional 
5 min before spinning them onto acid-washed coverslips (thickness 
of 1.5 H) on a glycerol cushion for 30 min at 30°C. Coverslips were fixed 
in methanol for 5 min at −20°C and stained for -tubulin (1:200; 1.5 hours, 
37°C; GTU88) and analyzed with a SP5 Leica confocal microscope.
Mitochondrial depolarization assay
T cells nucleofected with siCtrl or siCCT were sorted and stained with 
MitoTracker Orange (1 M; Molecular Probes/Invitrogen/Thermo- 
Fisher Scientific) for 1 hour at 37°C and stimulated with anti-CD3 + 
anti-CD28–coated beads for the times indicated, cooled on ice, 
fixed, stained for Tom20 (total mitochondrial mass), and analyzed 
by flow cytometry. Ratio of MitoTracker: Mitochondrial mass was 
calculated for each time point. Mean fluorescence intensity and Geo 
Mean of staining were analyzed with a LSRFortessa flow cytometer 
(BD Biosciences) and FlowJo v10.1 software (TreeStar).
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Mitochondrial stress test
To measure the bioenergetics of the cells, siCtrl or siCCT human pri-
mary CD4 cells were cultured on Dulbecco’s modified Eagle’s medium 
(four donors, five replicates) on XFe96 FluxPak (Agilent Technolo-
gies) following the manufacturer’s instructions. Respiration was 
measured with an XFe96 extracellular flux analyzer (Seahorse Bio-
science). Cells were seeded at 0.8 × 106 per well and activated with 
anti-CD3 + anti-CD28 tetramers (25 l/106 cells; Stem Cell). Drugs 
were injected as follows: oligomycin (1 M), Carbonyl Cyanide m- 
chlorophenylhydrazine (CCCP)  (1.5 M), rotenone (1 M), and antimycin A 
(1 M). Results were analyzed with Seahorse Wave software and subjected 
to a linear mixed model statistical analysis (R 3.6.3 version; https://stats.
idre.ucla.edu/other/mult-pkg/introduction-to-linear-mixed-models/).
ATP fluorometric assay
To measure ATP content, 3.106 siCtrl or siCCT human primary 
CD4 cells were activated with anti-CD3 + anti-CD28 tetramers 
(15 l/106 cells; Stem Cell) and lysed in ATP assay buffer from an 
ATP assay kit (Abcam ab83355), deproteinized with 4 M perchloric acid, 
and neutralized with 2 M KOH. Samples were cold-iced throughout 
the process. Enzymatic reactions were performed following the 
manufacturer’s instructions, and fluorometric assays were read with 
a Fluoroskan Ascent (ThermoLabsystem).
Flow cytometry, sorting, and ELISA
Cell conjugates were allowed to form for 18 hours, and supernatants and 
cells were collected for enzyme-linked immunosorbent assay (ELISA) 
and flow cytometry, respectively. A specific ELISA detection kit (Dia-
Clone) was used to quantify the levels of IL-2 secreted, and colorimetric 
intensity levels were detected on a Bio-Rad plate reader with a 450-nm 
filter. For flow cytometry analysis, staining was performed with 
anti- human CD69-allophycocyanin (BD Biosciences) and anti-human 
CD3-phycoerythrin (PE) in fluorescence-activated cell sorting (FACS) 
blocking solution [1% BSA, 1% FBS, human -globulin (100 g/ml), and 
0.01% sodium azide in PBS] for 30 min at 4°C. Other stainings were as 
follows: CD4 purification control: anti-human CD19-PE, CD8-V500, 
CD4-V450, DR-perCP, CD3-APC, CD45Ro-Cy7, and CD45RA-FITC; 
CD3 surface expression: anti-human CD3-FITC or isotype control- 
FITC, CD28-PE, and CD11a allophycocyanin; anti-human CD3 (T3b) 
or control X63 clone, anti-mouse-allophycocyanin; and anti-CD28-PE. 
Mitochondrial mass was assessed in cells labeled with nonyl- acridine 
orange (25 nM) for 15 min at room temperature and stained for CD3- 
allophycocyanin (4°C). Cell viability assays were performed with the 
Annexin V–CF Blue/7-aminoactinomycin D (7-AAD) Apoptosis 
Detection kit (Abcam ab214663), following the manufacturer’s instruc-
tions. Mean fluorescence intensity and Geo Mean of staining were ana-
lyzed with a FACS-Canto II 3L, a FCAS-Canto II HTS or a LSR Fortessa 
flow cytometer with FACSDiva software (BD Biosciences), and FlowJo 
v10.1 software (TreeStar). Sorting was performed by separating GFP+ 
cells in a digital flow sorter FACSAria Cytometer with FACSDiva soft-
ware (BD Biosciences) 48 hours after transfection.
STED, time-lapse confocal and TIRFm videos
STED images were acquired using a Leica SP8 gSTED 3D system 
equipped with a pulsed white light laser (WLL; range, 470 to 670 nm) 
as an excitation source and 660 or 592 nm as the STED depletion 
sources. All images were acquired using a HC PL Apo CS2 100×/1.4 
oil objective and accompanying Application Suite X software (LAS 
X, 3.5.2. 18963; Leica Microsystems GmbH). Line scan speed of 1000 Hz 
was used, combined with bidirectional scanning. Alexa 488 [chicken 
anti-GFP (Abcam) plus Alexa 48–conjugated anti-chicken (Invitrogen) 
antibodies] and MitoTracker Orange or Alexa 568 [anti-Giantin 
(Abcam) plus Alexa 568–conjugated anti-rabbit antibodies] were im-
aged with 488- and 568-nm excitation and 592- and 660-nm deple-
tion wavelengths, respectively. The depletion laser power was 111 mW. 
Alexa 647–conjugated phalloidin fluorescence was acquired in con-
focal mode. Fluorescence-emitted light was collected with HyD hybrid 
detectors for all fluorochromes. Image processing was performed 
with Fiji software (ImageJ) for fluorescence images and 3D re-
construction and with Imaris software for detection of volumes and 
3D reconstruction in the case of Jurkat T cell line and SEE-pulsed 
Raji (APCs) conjugates. The 3D rendering mode from LAS X soft-
ware 4.0.0.11706 (Leica Microsystems GmbH) was used for volume 
reconstructions of mitochondria in Jurkat T cells forming IS on stim-
ulating surfaces. For cell conjugates, 4D imaging was performed 
using 5 × 105 CMAC (7-amino-4-chloromethylcoumarin)–loaded 
Raji APCs [SEE-pulsed (E1-6 Jurkat cells), SEB-pulsed (CH7C17 
Jurkat cells), or unpulsed] allowed to adhere to fibronectin-coated 
glass-bottom 35-mm dishes (no. 1.5; MatTek Corporation, Ashland, 
MA, USA). Cells were maintained in 2 ml of HBSS containing 1% 
FBS and 25 mM Hepes. T cells were added (1:1 ratio), and a series 
of fluorescence and bright-field frames were captured using a TCS 
SP5 confocal laser scanning unit (Leica Microsystems) attached to 
an inverted epifluorescence microscope (DMI6000) fitted with an HCX 
PL Apo 63×/1.40 to 0.6 oil objective. Images were acquired and 
processed with the accompanying Leica confocal software (LCS; Leica 
microsystems, GmbH) and ImageJ software (http://rsbweb.nih.gov/ij/). 
A Leica SP8 Navigator confocal microscope equipped with a pulsed 
WLL (range, 470 to 670 nm) and an HC PL Apo CS2 100×/1.4 oil 
objective and accompanying Application Suite X software (LAS X, 3.5.2. 
18963; Leica Microsystems GmbH) was used to acquire the confocal 
images for fixed cell conjugates of Jurkat T cells and Raji cells 
(CMAC-labeled and pulsed or not with SEE and stained for CD3). 
For 4D resonant scanning rapid acquisition of EB3-GFP–transfected 
cells, the TCS SP5 confocal laser scanning unit (Leica Microsystems) 
was used in resonant scanner mode, with 1 to 2 s for each Z-scan, 
allowing whole- cell recording. Bright-field images and fluorescence 
images were acquired. For TIRFm, T cells transfected with corre-
sponding siRNAs, EB3-GFP, EB3-RFP, CD3-mCherry, or MAP7-GFP 
were allowed to settle onto glass-bottom dishes coated with anti-CD3 
(10 g/ml) and anti-CD28 (3 g/ml). For cells pretreated with CHX 
(20 g/ml for 40 min) or BTZ (520 nM for 2 hours), the drug was 
maintained in the imaging medium during acquisition. Recording was 
initiated 3 min after cells were plated, and cells were visualized with a 
Leica AM TIRF MC M system mounted on a Leica DMI6000B micro-
scope coupled to an Andor-DU8285_VP-4094 camera fitted with a 
HCX PL Apo 100.0×/1.46 oil objective. Images were processed with 
the accompanying confocal software (LCS; Leica). Time-lapse settings 
were optimized for each type of experiment and are specified through-
out the text. The laser penetrance used was 150 nm for both laser 
channels (488 and 561 nm). Synchronization was performed with the 
accompanying Leica software, and images were processed with Leica 
software and ImageJ software (http://rsbweb.nih.gov/ij/).
cryo-SXT data acquisition and image processing
Isolated peripheral blood CD4 cells from healthy donors or Jurkat 
T cells were cotransfected with EB3-GFP and the corresponding 
siRNAs (siCtrl or siCCT) and treated with IL-7 for survival for 48 hours. 
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GFP+ cells were sorted and subsequently incubated for 20 min with 
MitoTracker Red to label mitochondria (facilitating correlative mi-
croscopy and fast cryo-epifluorescent analysis of the grid quality). 
After that, 104 cells were deposited on specific stimulating-layer grids 
to form an IS. The stimulating surface used was similar to the one 
used for TIRFm (20). Holey carbon–coated (R 2/2; Quantifoil) Au-electron 
microscopy (EM) finder grids were incubated for 8 hours at 4°C 
with activated -CD3 (20 g/ml) and -CD28 (3 g/ml) antibodies to 
generate a stimulating carbon surface. For control grids without stimuli, 
carbon surface was incubated with poly-l-lysine. Cells were incubated for 
20 min at 37°C over the corresponding type of grid surface and fixed by 
plunge-freezing in an EM CPC vitrification unit (Leica Microsystems). 
Grids were maintained in liquid nitrogen during the whole process. 
Vitrified grids were first analyzed at liquid nitrogen temperature with the 
cryo-correlative cooling stage (Linkam Scientific Instruments). The cryo-
stage was then inserted into an AxioScope A1 (Carl Zeiss) epifluores-
cence microscope with an N-Achroplan 10×/0.25 Ph1 objective and 
imaged with a charge-coupled device (CCD) AxioCam ICm1 (Carl Zeiss).
Samples were previsualized with a visible light microscope on-
line within the x-ray microscope to correlate cell position with epi-
fluorescence and cryo-epifluorescence images. At the Mistral beamline 
(ALBA Synchrotron), zero degree soft x-ray projection mosaics were 
acquired to evaluate sample conditions (vitrification and thickness). 
Tilt series were acquired at 520-eV photon energy from −65° to 65° 
at 1° intervals, using a 25-nm zone plate. To avoid depth of focus arti-
facts, the x-ray tomography enhanced defocus (XTEND) scheme (38) 
was used to acquire tilt series. Exposure time depended on sample 
thickness and ranged in our work from 1 to 4 s. The final image pixel 
size was 10 nm. We used a beam time of 5 days corresponding to 
15 shifts at the Mistral microscope placed in the ALBA Synchrotron. 
We acquired 48 XTEND1 datasets per cell (one dataset is equal to 
three inclined series). The 48 datasets from single cells corresponded to 
16 siCtrl resting cells, 9 siCtrl cells forming IS, 13 siCCT resting cells, 
and 10 siCCT cells forming IS. To monitor experimental resolution 
of the tomograms, we used Nyquist criteria associated with the line 
spread function.
Protein digestion, peptide labeling, and fractionation 
for proteomics
For label-free experiments, centrosomal-enriched fractions from 
resting or activated Jurkat T cells were isolated as described in (16), 
and two biological replicates were analyzed for protein content. 
Centrosomal-enriched fractions from resting or activated T lympho-
blasts from healthy donors were processed as described and subjected 
to iTRAQ. For isobaric labeling, three different experiments, each 
comprising two biological replicates for each condition, were ana-
lyzed in three independent iTRAQ 4-plex experiments. Proteins for 
label-free or iTRAQ analysis were digested using the in-gel digestion 
protocol as previously described (47), with some modifications. Briefly, 
supernatants were run by conventional SDS-PAGE until the front 
entered the resolving gel. The protein band containing the whole 
proteome was visualized by colloidal Coomassie staining, destained 
with water, and bands were excised and cut into cubes. Samples were 
subjected to reduction with 10 mM dithiothreitol and alkylation in 
50 mM iodoacetamide and digested overnight at 37°C with modified 
trypsin (60 ng/ml; Promega, Madison, WI, USA) at a 12:1 protein:trypsin 
(w/w) ratio in 50 mM ammonium bicarbonate (pH 8.8) containing 
10% acetonitrile. The resulting tryptic peptides were extracted by 
incubation in 12 mM ammonium bicarbonate (pH 8.8) and, later, 
0.5% TFA (trifluoroacetic acid), which was added at a final concen-
tration of 1%, and the peptides were lastly desalted in C18 Oasis- 
hydrophilic-lipophilic-balanced (HLB) cartridges and dried-down 
for further analysis.
For stable isobaric labeling, the resulting tryptic peptides were 
dissolved in 500 mM triethylammonium bicarbonate buffer, and 
the concentration of peptides was determined by measuring amide 
bonds with the Direct Detect system (Millipore). Equal amounts of 
each peptide sample were labeled using the 4-plex iTRAQ Reagents 
Multiplex Kit (Applied Biosystems, Foster City, CA, USA) according 
to the manufacturer’s protocol. Each peptide solution was inde-
pendently labeled with one iTRAQ reagent vial previously reconstituted 
in isopropanol. After incubation at room temperature for 1 hour, the 
reaction was stopped with 0.5% TFA, incubated for 15 min, and 
peptides were combined. Samples were concentrated in a Speed Vac, 
desalted in C18 Oasis-HLB cartridges, and dried-down for further 
analysis. For increasing proteome coverage, iTRAQ-labeled samples 
were separated into four fractions by mixed-cation exchange chro-
matography (Oasis HLB-MCX columns), which were desalted be-
fore tandem mass spectrometry (MS/MS) analysis. For label-free 
experiments, the resulting tryptic peptide mixtures were dissolved 
in 0.5% TFA for MS/MS analysis.
LC-MS analysis
Labeled peptides were loaded into the liquid chromatography–MS/MS 
(LC-MS/MS) system for on-line desalting in C18 cartridges and ana-
lyzed by LC-MS/MS using a C-18 reversed phase nanocolumn (75 m 
internal diameter × 50 cm; 2 m particle size; Acclaim PepMap rapid 
separation liquid chromatography (RSLC), 100 C18; Thermo Fisher 
Scientific) in a continuous acetonitrile gradient consisting of 0 to 30% 
B in 360 min, 50 to 90% B in 3 min (A = 0.5% formic acid; B = 90% 
acetonitrile and 0.5% formic acid). A flow rate of 200 ml/min was used 
to elute peptides from the reversed-phase (RP) nanocolumn to an emit-
ter nanospray needle for real-time ionization and peptide fragmenta-
tion on a Q Exactive mass spectrometer (Thermo Fisher Scientific). An 
enhanced Fourier Transform (FT)–resolution spectrum (resolution = 
70,000) followed by MS/MS spectra from the 20 most intense parent 
ions were analyzed along the chromatographic run. Higher-energy 
collisional dissociation (HCD) fragmentation was performed at 30% of 
normalized collision energy and 17,500 resolution; dynamic exclusion 
was set at 30 s.
Database search
For isobaric labeling experiments, all searches were performed with 
Proteome Discoverer (version 1.4, Thermo Fisher Scientific) using 
SEQUEST (Thermo Fisher Scientific) against a UniProt database 
containing all sequences from human (March 2013; 70,136 entries), 
supplemented with 47 sequences from the cRAP (common Repository of 
Adventitious Proteins) database, containing the most common labora-
tory protein contaminants (Global Proteome Machine). For database 
searching, parameters were selected as follows: trypsin digestion with 
two maximum missed cleavage sites, precursor mass tolerance of 
2 Da, and fragment mass tolerance of 30 ppm. Methionine oxidation 
(+15.994915) was set as a variable modification, whereas lysine and 
peptide N-terminal modification (+144.102063 Da), and cysteine car-
bamidomethylation (+57.021464) were set as fixed modifications. 
The same collections of MS/MS spectra were also searched against 
inverted databases constructed from the same target databases. 
Peptide identification from MS/MS data was performed using the 
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probability ratio method. False discovery rate (FDR) of the peptide 
identifications was calculated using the refined method; 1% FDR 
was used as a criterion for peptide identification. Each peptide was 
assigned only to the best protein proposed by the Proteome Discoverer 
algorithm.
For label-free experiments, tandem mass spectra and charge state 
deconvolution were extracted by Proteome Discoverer version 1.4 
using SEQUEST (Thermo Fisher Scientific) and X! Tandem 
[The global proteome machine (GPM), thegpm.org; version 
2007.01.01.1]. SEQUEST was set up to search MSIPI_human_3.67.
fasta (87040 entries) assuming trypsin. X! Tandem was set up to 
search a subset of the MSIPI_human_3.67 database also assuming 
trypsin. SEQUEST and X! Tandem were searched with a fragment 
ion mass tolerance of 30 ppm and a parent ion tolerance of 15 ppm. 
Iodoacetamide derivative of cysteine was specified in SEQUEST 
and X! Tandem as a fixed modification. Deamidation of asparag-
ine and glutamine and oxidation of methionine were also specified 
as variable modifications. Scaffold (version Scaffold_4.6.1, Proteome 
Software Inc., Portland, OR) was used to validate MS/MS-based 
peptide and protein identifications. Peptide identifications were ac-
cepted if they could be established at greater than 95.0% probability 
by the Peptide Prophet algorithm. Protein identifications were ac-
cepted if they could be established at greater than 99.0% probability 
and contained at least one identified peptide. Protein probabilities 
were assigned by the Protein Prophet algorithm. Proteins that con-
tained similar peptides and could not be differentiated on the basis 
of MS/MS analysis alone were grouped to satisfy the principles of 
parsimony.
Peptide quantification and statistical analysis
In the isobaric labeling experiments, quantitative information from 
MS/MS spectra was extracted from msf files using an in-house SQLite 
script. The quantitative information was integrated from the spectrum 
level to the peptide level and then to the protein level on the basis of 
the weighted spectrum, peptide and protein (WSSP) model (48), using 
the generic integration algorithm. Briefly, for each sample i, the values 
xqps = log2Ai/C were calculated, where Ai is the intensity of the iTRAQ 
reporter corresponding to activated sample i in the MS/MS spectrum s 
coming from peptide p and protein q, and C is the intensity of the 
iTRAQ reporter from the corresponding control sample. The log2 
ratio of each peptide (xqp) was calculated as the weighted average of 
its spectra, the protein values (xq) were the weighted average of its 
peptides, and the grand mean ( ̄  x) was calculated as the weighted 
average of all the protein values (48). The statistical weights of spec-
tra, peptides, and proteins (wqps, wqp, and wq, respectively), and the 
variances at each of the three levels (  S 
2,   P 
2 , and   Q 
2 , respectively) 
were calculated as described (48). Protein quantifications were 
further integrated among the six comparisons, obtaining averaged 
values (xq′) with their corresponding weights (wq ′) for every pro-
tein (48). The Systems Biology analysis was performed according to 
the SBT approach (19). Briefly, averaged proteins were grouped into 
functional categories using Ingenuity Knowledge Database (IPA), 
CORUM, and DAVID. For each category, the log2 ratio (xc) was 
calculated as the weighted average of its proteins, and the statistical 
weights (wc) of categories were calculated as previously described 
(19). Protein-to-category outliers were removed at 1% FDR to end 
up with categories containing proteins with a coordinated behavior 
(19). Significant abundance changes of proteins or categories in the 
activated samples compared to controls were detected at 1% FDR.
SXT image quantification and statistical analysis
Automatic tilt-series preprocessing was performed following the pre-
viously described procedure (38). Integrated tilt series were aligned 
with IMOD and reconstructed with TOMO3D software (30 iterations 
of the SIRT algorithm). Semiautomatic segmentation of volumes was 
carried out with SuRVoS, and volumes were represented with Chimera. 
PCM and Mitochondrial statistics are calculated from segmented 
data. Centriolar angles and distances were calculated from 3D cen-
triolar coordinates. Two points, placed in upper and lower center of 
the cylinder, determine the length and centriolar vector, while four 
points, perpendicular to this vector on the centriolar wall, were used 
to calculate the cylinder radius. In addition, four markers pointed 
to carbon surface to calculate A and alpha angles and D distance. 
Statistical analyses were performed using in-house Python scripts 
(Anaconda Software Distribution; versions 2 to 2.4.0. Anaconda Inc., 
November 2017; https://anaconda.com).
Quantification of microtubule plus-ends (TIPs) and vesicles 
through TIRFm
Acquisition and quantification as well as statistical analysis was 
performed as described in (49) for MT growth and vesicle traffic at 
the IS.
Densitometry analysis and quantification of Western blot
Bands from Western blots were analyzed with accompanying soft-
ware Image Gauge (Fujifilm Inc). Background was subtracted, and 
arbitrary unit per pixel was normalized to control samples, not stim-
ulated. Values were analyzed with GraphPad for significance.
General statistical analysis
Statistical significance of difference in values was calculated by para-
metric or nonparametric test, either analysis of variance (ANOVA), 
Kruskal-Wallis, Student’s t test, or Mann-Whitney, where applicable, 
upon normal distribution analysis, or when n < 30. P values are de-
noted as follows: *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. 
Exact P values are also indicated in the figures (Python Software and 
Prism, GraphPad).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/49/eabb7242/DC1
View/request a protocol for this paper from Bio-protocol.
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